Copyright
©The Author(s) 2021.
World J Gastroenterol. Jun 28, 2021; 27(24): 3643-3653
Published online Jun 28, 2021. doi: 10.3748/wjg.v27.i24.3643
Published online Jun 28, 2021. doi: 10.3748/wjg.v27.i24.3643
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
Age | 26 yr | 31 yr | 52 yr | 49 yr | 39 yr | 35 yr | 61 yr | 26 yr | 54 yr | 44 yr | 45 yr | 48 yr |
Sex | Male | Female | Female | Female | Male | Female | Male | Female | Male | Male | Male | Female |
CPF Parks classification (number of fistulas) | Transsphinc | Transsphinc | Suprasphinc | Transsphinc | Transsphinc | Transsphinc | Transsphinc | Transsphinc | Suprasphinc | Transsphinc | Transsphinc | Suprasphinc |
Number of internal/exter | 2/2 | 2/2 | 1/1 | 2/2 | 2/2 | 1/2 | 2/2 | 1/1 | 2/2 | 1/2 | 1/2 | 1/1 |
Length of fistula tract | 3 cm each | 3 cm each | 4 cm | 2 cm; 5 cm | 10 cm; 1.5 cm | 12 cm; 1.5 cm | 3 cm; 7 cm | 3 cm | 6.5 cm; 2.5 cm | 2.5 cm; 2.5 cm | 3.0 cm; 3.0 cm | 3.0 cm |
Previous medical treatment | Azathioprin | Azathioprin Infliximab | Azathioprin | Azathioprin | Azathioprin | Azathioprin | Azathioprin Infliximab | Azathioprin | Adalimumab | Azathioprin Adalimumab | Infliximab | Azathiopron Antibiotics |
Actual medical treatment | Adalimumab | Ustekinumab | Azathioprin | None | Ustekinumab | Vedolizumab | Ustekinumab | Infliximab | Infliximab | Infliximab | Adalimumab | None |
Previous surgical treatment for abscess and fistula | Multiple abscess excisions, previous fistula surgery (1) | Multiple abscess excisions, previous fistula surgery (1) | Multiple abscess excisions,previous fistula surgery (3) | Multiple abscess excisions, previous fistula surgery (2) | Multiple abscess excisions, previous fistula surgery (3) | Multiple abscess excisions, previous fistula surgery (2) | Multiple abscess and fistula surgeries (11) | Multiple abscess and fistula surgery (4) | Multiple abscess and fistula surgery (4) | Multiple abscess and fistula surgery (4) | Multiple abscess and fistula surgery (3) | Multiple abscess and fistula surgery (9) |
Previous treatment (stoma) | No | Yes | No | Yes | No | No | No | No | No | Yes | Yes | No |
Seton drainage prior to Darvadstrocel (duration) | Yes (6 wk) | Yes (4 mo) | Yes (10 mo) | Yes (18 mo) | Yes (8 wk) | Yes (12 wk) | Yes (9 mo) | Yes (60 wk) | Yes (36 wk) | Yes (48 wk) | Yes (24 wk) | Yes (12 wk) |
Method of closure of internal opening | Suture (1), mucosal flap (1) | Suture (2) | Suture (1) | Suture (2) | Suture (2) | Suture (1) | Suture (2) | Suture (1) | Suture (2) | Suture (1) | Suture (1) | Suture (1) |
Intraoperative adverse events | No | No | No | No | No | No | No | No | No | No | No | No |
Postoperative adverse events | No | No | No | No | No | No | No | No | No | No | Fewer (day 2) | No |
- Citation: Schwandner O. Stem cell injection for complex anal fistula in Crohn’s disease: A single-center experience. World J Gastroenterol 2021; 27(24): 3643-3653
- URL: https://www.wjgnet.com/1007-9327/full/v27/i24/3643.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i24.3643